Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Abstract: This microprocessor explores an architectural solution to scalability problems in scalar operand networks. The 0.15/spl mu/m 6M process, 331 mm/sup 2/ research prototype issues 16 unique ...
Abstract: Objective: The current vector velocity measurement techniques are typically limited by probe apertures, which restrict their use to superficial vessels. This work introduces a high frame ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results